Barac, AleksandraBartoletti, MicheleAzap, OzlemBussini, LindaErgonul, OnderKrause, RobertPaño-Pardo, José RamónPower, Nicholas RRodríguez-Baño, JesúsSibani, MarcellaSzabo, Balint GergelyTsiodras, SotiriosVerweij, Paul EQuirós, Alejandro MartínZollner-Schwetz, Ines2023-05-032023-05-032022-03-23http://hdl.handle.net/10668/22130enCOVID-19ClinicalESCMID guidelinesIvermectinTreatmentHumansIvermectinPandemicsSARS-CoV-2COVID-19 Drug TreatmentInappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere!research article35337977open access10.1016/j.cmi.2022.03.0221469-0691PMC8942456http://www.clinicalmicrobiologyandinfection.com/article/S1198743X22001616/pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942456/pdf